Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Letter From The Editor

Last week I was in the checkout lane at a grocery store and noticed how many magazines there were for diabetes and weight loss. It seems that almost every one of the headlines had something to do with eating more fat to lose weight. I looked at the articles and I saw exactly why they sell but don't necessarily help. It seems that the message is "Eat anything you want as long as you have plenty of fat." This never works in the real world as patients eat all that fat with rice, or pasta and then they down sodas or other sugary drinks that actually pack on the pounds and there A1c's climb. This week our items #5, #6 and #11 all lay a great foundation for the correct way to talk to your patients.

Often the United States is rated as the country with the most patient errors in the healthcare system. Many health professionals say this is because we have a disjointed system with many providers and payers, and that this makes the US an incubator for disconnected coverage. The field of providers is going to shrink by one now as Aetna is buying Humana. That means at least 33 million Americans will be under coordinated care.


Announcements: Sunday, July 5, 7PM ET

From "The life and times of diabetes pioneer Elliot Joslin; ten things to hate about diabetes; and finding help and hope on the internet." Sundays live online at at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at

We can make a difference!


Dave Joffe, Editor-in-chief

Read More
Scroll down for items in the current newsletter

Tool for your Practice


This is the most current and complete diabetes drug list available with all the information that you need to thoroughly analyze both the positive and negative effects of current medications. Over 21 points of interest on every diabetes drug from patient education to a photo of every tablet, including contraindications and precautions, adverse effects, drug interactions with potential for clinical significance, dosing, effect on A1c, cost and much more. Download the Diabetes Drug List here (PDF format - 65 pages)


Product of the Week


NeuroMetrix's Quell chronic pain management device is the over-the-counter version of a previous NeuroMetrix device called Sensus. It uses nerve stimulation to treat multiple types of chronic pain, including diabetic neuropathy and fibromyalgia. Quell stands out as one of the only FDA-cleared non-drug therapies for chronic pain relief. Quell is worn in a strap that wraps around the upper calf, sending electrical pulses through the skin to the sensory nerves that in turn signal the brain to trigger the body's natural pain relief response, blocking pain signals throughout the body. It can be worn for long periods of time, including during sleep. The device is about the same thickness as an iPhone 5, relatively lightweight, and its strap resembles a sports band that can be hidden under clothes.



Mobile App of the Week 


ControlMyWeight doesn't tell your patients what to eat but just helps them to become more aware of their eating habits so that they can slowly make the smarter choices that will lead to weight control. More information.





Test Your Knowledge Question #788

A 78-year-old patient with a 15-year history of type 2 diabetes arrives in your office for a check-up. He suffers from stage 3 chronic kidney disease and lives alone. From previous visits you have learned he has very few support services. What would be a realistic A1C treatment target for this individual?

A. A1C 6.0-6.5%

B. A1C 7.5-8.0%

C. A1C 8.5-10.0%

D. A1C 10.5-11%

For the complete question and answer, just follow this link. 


Diabetes In Control Has Over 16000 Studies & Articles In Our Archives

Quote of the Week!

"Learning is not attained by chance, it must be sought for with ardor and diligence."
                                                           ...Abigail Adams

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week's newsletter: 

Ashley Spies, USF College of Pharmacy
Shatera Peace, FAMU
Thao Luutran, LECOM
L'Shantey Wells, Creighton College of Pharmacy
Diane Jules, USF College of Pharmacy


Cast Your Vote
Are you seeing more diabetic patients due to the Affordable Care Act?

CME/CE of the Week
Martha Funnell, RN

Category: Nutrition
Credits: .75